That said, cancer cell-specific AIF knockout only partially inhibited OXPHOS, meaning that it did not completely disrupt mitochondrial bioenergetics, yet yielded tangible effects on tumor incidence and progression. The gene discussed is AIFM1; the disease is cancer.